Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_235640.htm |
| EX-31.1 - EXHIBIT 31.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_235639.htm |
| EX-24.1 - EXHIBIT 24.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_235638.htm |
| EX-21.1 - EXHIBIT 21.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_235636.htm |
| 10-K - FORM 10-K - NAVIDEA BIOPHARMACEUTICALS, INC. | navb20201231_10k.htm |
Exhibit 23.1
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We consent to the incorporation by reference in the Registration Statement of Navidea Biopharmaceuticals, Inc. on Form S-3 (File Nos. 333-248404, 333-252847, 333-235762, 333-222092, 333-195806, 333-193330, 333-184173, 333-173752, 333-168485, 333-76151, and 333-15989) and Form S-8 (File Nos. 333-250078, 333-238329, 333-228960, 333-217814, 33-81410, 333-119219, 333-130636, 333-130640, 333-153110, 333-158323, 333-183317, 333-05143, 333-21053, and 333-198716) of our report dated March 26, 2021, with respect to our audits of the consolidated financial statements of Navidea Biopharmaceuticals, Inc. as of December 31, 2020 and 2019 and for the years then ended, which report is included in this Annual Report on Form 10-K of Navidea Biopharmaceuticals, Inc. for the year ended December 31, 2020.
/s/ Marcum LLP
Marcum LLP
New Haven, Connecticut
March 26, 2021
